VJHemOnc is committed to improving our service to you

EBMT 2020 | CD4+ T-cell reconstitution in allo-HSCT settings

VJHemOnc is committed to improving our service to you

Jaap Jan Boelens

Jaap Jan Boelens, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the use of early CD4+ T-cell reconstitution as a predictor of outcomes after allogeneic hematopoietic stem cell transplantation (allo-HSCT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter